KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Teva Pharmaceutical Industries (TEVA) FCF Payout Ratio (2017 - 2018)

Historic FCF Payout Ratio for Teva Pharmaceutical Industries (TEVA) over the last 10 years, with Q1 2018 value amounting to 0.01.

  • Teva Pharmaceutical Industries' FCF Payout Ratio rose 10017.17% to 0.01 in Q1 2018 from the same period last year, while for Dec 2018 it was 0.01, marking a year-over-year decrease of 9899.76%. This contributed to the annual value of 0.23 for FY2019, which is 338804.19% up from last year.
  • Teva Pharmaceutical Industries' FCF Payout Ratio amounted to 0.01 in Q1 2018, which was up 10017.17% from 0.15 recorded in Q4 2017.
  • In the past 5 years, Teva Pharmaceutical Industries' FCF Payout Ratio registered a high of 10.52 during Q4 2014, and its lowest value of 33.95 during Q4 2016.
  • In the last 5 years, Teva Pharmaceutical Industries' FCF Payout Ratio had a median value of 0.04 in 2016 and averaged 1.72.
  • Within the past 5 years, the most significant YoY rise in Teva Pharmaceutical Industries' FCF Payout Ratio was 255811.42% (2017), while the steepest drop was 1342545.45% (2017).
  • Over the past 5 years, Teva Pharmaceutical Industries' FCF Payout Ratio (Quarter) stood at 10.52 in 2014, then tumbled by 65.57% to 3.62 in 2015, then plummeted by 1037.79% to 33.95 in 2016, then surged by 100.43% to 0.15 in 2017, then tumbled by 93.87% to 0.01 in 2018.
  • Its FCF Payout Ratio was 0.01 in Q1 2018, compared to 0.15 in Q4 2017 and 0.21 in Q3 2017.